News
Intuitive Surgical (Nasdaq: ISRG) announced today that the FDA cleared the latest advanced energy instrumentation for its da ...
The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...
FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...
A growing disconnect remains between what generics are approved and what are actually accessible, GoodRx said.
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...
ARS Pharmaceuticals' Neffy, an epinephrine nasal spray, is poised as a game-changer for emergency allergies, driving growth.
The FDA on Thursday said it published more than 200 decision letters, known as complete response letters, that it issued in response to applications for approval of drugs or biological products ...
Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and ...
Here’s what else you need to know to get up to speed and on with your day. For months, officials at FEMA have been warning ...
Contingency management interventions for stimulant and opioid use disorders should offer $128 per week for vouchers or $55 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results